Marché Fermé -
Autres places de cotation
|
Après clotûre 22:00:01 | |||
5,97 EUR | -0,33% |
|
6,365 | +6,62% |
27/06 | Les plus fortes hausses de la mi-journée | MT |
27/06 | Mise à jour sectorielle : Les actions du secteur de la santé sont mixtes en pré-marché jeudi | MT |
Métier
Dirigeants
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Mark Iwicki
CEO | Chief Executive Officer | 57 | 01/03/15 |
Mary Reumuth
DFI | Director of Finance/CFO | 48 | 01/02/14 |
Todd Bazemore
PSD | President | 53 | 20/11/17 |
Compliance Officer | 51 | 03/04/18 | |
Romulus Brazzell
CTO | Chief Tech/Sci/R&D Officer | 71 | 01/02/13 |
Investor Relations Contact | - | - | |
Darius Kharabi
PRN | Corporate Officer/Principal | 45 | 15/11/21 |
Administrateurs
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Andrew Koven
BRD | Director/Board Member | 66 | 28/09/17 |
Gregory Perry
BRD | Director/Board Member | 63 | 05/03/18 |
Howard Rosen
BRD | Director/Board Member | 66 | 06/01/14 |
Charles Myers
BRD | Director/Board Member | 70 | 15/10/21 |
Mark Blumenkranz
BRD | Director/Board Member | 73 | 15/11/21 |
Mark Iwicki
CEO | Chief Executive Officer | 57 | 01/03/15 |
Marjan Farid
BRD | Director/Board Member | 50 | 31/10/22 |
Classe d'actions
Vote | Nombre | Flottant | Autocontrôle | Flottant Total | |
---|---|---|---|---|---|
Action A | 0 | 2 928 | 0 | 0 | 91,40 % |
Action B | 1 | 2 816 454 | 2 574 136 ( 91,40 %) | 0 | |
Action C | 0 | 51 246 | 0 | 0 |
Coordonnées société
![Adresse KALA BIO, Inc.(27F0)](https://cdn.zonebourse.com/static/address/50920027.png)
Secteur
![Consensus](/images/consensus_flch.gif)
Révisions de BNA
Varia. 1 janv. | Capi. | |
---|---|---|
+56,89% | 809 Md | |
+39,52% | 624 Md | |
-6,55% | 351 Md | |
+7,92% | 289 Md | |
+13,74% | 240 Md | |
+13,83% | 220 Md | |
-0,49% | 219 Md | |
+7,94% | 166 Md | |
-2,57% | 157 Md |
- Bourse
- Actions
- Action KALA
- Action 27F0
- Société KALA BIO, Inc.